Darier disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:218OMIM:124200Q82.8
Who is this for?
Show terms as
3FDA treatments1Active trials18Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Darier disease, also known as Darier-White disease, keratosis follicularis, or dyskeratosis follicularis, is a rare inherited skin disorder caused by mutations in the ATP2A2 gene, which encodes the SERCA2 calcium pump essential for cell-to-cell adhesion in the skin. The disease is characterized by a disruption in the normal process of keratinization, leading to loss of adhesion between skin cells (acantholysis) and abnormal keratinization (dyskeratosis). The hallmark clinical features include greasy, warty, skin-colored or brownish papules that tend to coalesce into plaques, primarily affecting seborrheic areas such as the chest, back, scalp, forehead, and skin folds (groin, axillae). These lesions often have a distinctive unpleasant odor due to secondary bacterial infection. Nail abnormalities are very common and include longitudinal red and white streaks, V-shaped nicking at the free edge of the nail, and subungual hyperkeratosis. Small pits or punctate keratoses on the palms and soles (palmar pits) are another characteristic finding. Mucous membranes, particularly the oral mucosa, may also be affected with whitish papules. The disease typically worsens with heat, humidity, sun exposure, friction, and sweating. Some patients also experience neuropsychiatric manifestations, including mood disorders, epilepsy, and learning difficulties, though the relationship to the underlying genetic defect is still being studied. There is currently no cure for Darier disease. Management focuses on symptom control and prevention of flares. Mild cases may be managed with emollients, sun protection, and avoidance of triggers such as heat and friction. Topical retinoids and topical corticosteroids can be helpful for localized disease. For moderate to severe cases, oral retinoids such as acitretin or isotretinoin are the mainstay of treatment and can significantly reduce the severity of skin lesions. Secondary bacterial, viral (particularly herpes simplex), and fungal infections are common complications that require prompt treatment. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Subungual hyperkeratotic fragmentsHP:0008410Hyperkeratotic papuleHP:0045059AcrokeratosisHP:0200016BlepharitisHP:0000498Fragile nailsHP:0001808Anal mucosal leukoplakiaHP:0005212Palmar pitsHP:0010610Plantar pitsHP:0010612Cobblestone-like hyperkeratosisHP:0031288Longitudinal erythronychiaHP:6001074
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Nov 2024Characterization of the Cytokine Profile and the Microbiome in Darier's Disease

University Hospital, Toulouse — NA

TrialRECRUITING
May 2023Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning

State Institution "Republican Scientific and Practical Center" Cardiology, Belarus — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

3 available

Urea 39.5% With 2% Salicylic Acid

UREA, SALICYLIC ACID· PureTek Corporation

Urea is useful for the treatment of hyperkeratotic conditions such as keratosis pilaris

Dermacure

UREA 41%· Oncora Pharma, LLC

Urea is useful for the treatment of hyperkeratotic conditions such as keratosis pilaris

Urea Cream 40 Percent

UREA· Method Pharmaceuticals, LLC

Urea is useful for the treatment of hyperkeratotic conditions such as keratosis pilaris

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Characterization of the Cytokine Profile and the Microbiome in Darier's Disease
N/A
Actively Recruiting
PI: Juliette Mazereeuw-hautier, MD (University Hospital of Toulouse) · Sites: Toulouse, Centre Hospitalier Universitaire de Toulouse · Age: 1899 yrs

Specialists

18 foundView all specialists →
JM
Juliette Mazereeuw-hautier, MD
Toulouse, Centre Hospitalier Universitaire de Toulouse
Specialist

Rare Disease Specialist

PI on 3 active trials
IM
Ivan Maiseyenka
Minsk
Specialist

Rare Disease Specialist

6 Darier disease publications
SK
Susanne Kimeswenger
Specialist
3 Darier disease publications
JW
Jakob D Wikstrom
Specialist
3 Darier disease publications
EG
Emmanuella Guenova
Specialist
3 Darier disease publications
WH
Wolfram Hoetzenecker
Specialist
3 Darier disease publications
MZ
Maggie H Zhou
Specialist
3 Darier disease publications
ME
Monika Ettinger
Specialist
2 Darier disease publications
JT
Judith Traxler
Specialist
2 Darier disease publications
SA
Sabine Altrichter
Specialist
2 Darier disease publications
TB
Teresa Burner
Specialist
2 Darier disease publications
GX
Grace Xiong
STANFORD, CA
Specialist
2 Darier disease publications
PC
Philip Curman
Specialist
2 Darier disease publications
WJ
William Jebril
Specialist
2 Darier disease publications
EB
Etty Bachar-Wikstrom
Specialist
2 Darier disease publications
AR
Aude MAZA RIOLAND
Specialist
PI on 1 active trial
SL
Shari R Lipner
NEW YORK, NY
Specialist
4 Darier disease publications
CS
Cory L Simpson
Specialist
4 Darier disease publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Darier disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Darier diseaseForum →

No community posts yet. Be the first to share your experience with Darier disease.

Start the conversation →

Latest news about Darier disease

Disease timeline:

New recruiting trial: Characterization of the Cytokine Profile and the Microbiome in Darier's Disease

A new clinical trial is recruiting patients for Darier disease

New trial: Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning

Phase NA trial recruiting. Carotid revascularization

New trial: Characterization of the Cytokine Profile and the Microbiome in Darier's Disease

Phase NA trial recruiting. skin biopsies and blood extraction

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Darier disease

What is Darier disease?

Darier disease, also known as Darier-White disease, keratosis follicularis, or dyskeratosis follicularis, is a rare inherited skin disorder caused by mutations in the ATP2A2 gene, which encodes the SERCA2 calcium pump essential for cell-to-cell adhesion in the skin. The disease is characterized by a disruption in the normal process of keratinization, leading to loss of adhesion between skin cells (acantholysis) and abnormal keratinization (dyskeratosis). The hallmark clinical features include greasy, warty, skin-colored or brownish papules that tend to coalesce into plaques, primarily affecti

How is Darier disease inherited?

Darier disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Darier disease typically begin?

Typical onset of Darier disease is juvenile. Age of onset can vary across affected individuals.

Are there clinical trials for Darier disease?

Yes — 1 recruiting clinical trial is currently listed for Darier disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Darier disease?

18 specialists and care centers treating Darier disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Darier disease?

2 patient support programs are currently tracked on UniteRare for Darier disease. See the treatments and support programs sections for copay assistance, eligibility, and contact details.